A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema.,Lymphatic Research and Biology

当前位置： X-MOL 学术 › Lymphat. Res. Biol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema.
Lymphatic Research and Biology ( IF 1.4 ) Pub Date : 2020-10-19 , DOI: 10.1089/lrb.2019.0064
Ahmet Akgul _{1,

2,

3} , Ela Tarakci _{2,

4} , Nilay Arman _{2,

4} , Tugba Civi _{2,

4} , Selin Irmak _{1,

2}

Affiliation

Background: Platelet-rich plasma (PRP) is an autologous concentrated preparation of platelets characterized by lymphangiogenetic and tissue-repairing effects. Although PRP has been safely used in many different fields, there is no clinical study regarding the use of PRP in lymphedema treatment in humans. We assessed the clinical outcomes of PRP in patients with lower extremity lymphedema (LEL) in a randomized controlled trial.

中文翻译：

一项随机对照试验，比较富血小板血浆、低水平激光治疗和复杂的减充血物理治疗对下肢淋巴水肿患者的治疗。

背景：富血小板血浆 (PRP) 是一种自体浓缩血小板制剂，具有淋巴管生成和组织修复作用。尽管 PRP 已安全地用于许多不同领域，但尚无关于在人类淋巴水肿治疗中使用 PRP 的临床研究。我们在一项随机对照试验中评估了 PRP 在下肢淋巴水肿 (LEL) 患者中的临床结果。

更新日期：2020-10-30

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>